Pharmafile Logo

Cresset announces scientific programs for User Group Meetings

June 1, 2016 – Biotechnology –

North American User Group Meeting: 1st June 2016, Cambridge, MA, USA

European User Group Meeting: 16th – 17th June 2016, Cambridge, UK

Cresset, innovative provider of software for small molecule discovery and design, is pleased to announce their North American and European User Group Meetings, both taking place in June 2016.

‘Our established User Group Meetings offer computational, medicinal and synthetic chemists the opportunity to hear from our customers and understand more about how Cresset solutions can increase the effectiveness of their discovery programs, ‘ says Dr Tim Cheeseright, Director of Products at Cresset. ‘Delegates will also have the opportunity to attend workshops where they will learn how to extract even more value from Cresset software. In our industry, where confidentiality is so important, it is a mark of respect for each other that we manage to share the inspiration and ideas behind our common scientific goals in a constructive way. I look forward to welcoming existing and prospective customers to both meetings.”

The North American scientific program features presentations from:

  • Boehringer Ingelheim: ëOne decade of Cresset software at Boehringer Ingelheimí

  • Broad Institute: ëMapping compound diversity using 3D field alignmentsí

  • Eli Lilly: íThe Open Innovation Drug Discovery (OIDD): Virtual screening – mining blindlyí

  • Novartis: ëAnalyzing building blocks diversity for DNA encoded library designí

  • Cresset: ‘Whatís new in Cresset software including upcoming structure-based design application’

The European scientific program features presentations from:

  • Boehringer Ingelheim: ëOne decade of Cresset software at Boehringer Ingelheimí

  • Eli Lilly: ëUses of field similarity in library design and sidechain enrichmentí

  • GSK: ëPrediction of cyclic peptide passive permeabilityí

  • Monsanto: ëTioxazafen, a new broad-spectrum seed treatment nematicideí
  • Novartis: ëAnalyzing building blocks diversity for DNA encoded library designí

  • Takeda: ‘Design of a focussed CNS screening collection at Takeda’

  • University of Hertfordshire: ‘In silico analysis of inhibitor interactions with efflux pumps and their substrates’

  • Cresset: ‘Whatís new in Cresset software including upcoming structure-based design application’

Participation is free of charge and online registration is open now:

Cresset Group
info@cresset-group.com
New Cambridge House, Bassingbourn Road, Litlington, Cambridgeshire, SG8 0SS, United Kingdom